Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study

Citations

WEB OF SCIENCE

9
Citations

SCOPUS

9

초록

Background & Aims: It is unclear if there may be sex differences in response to nucleos(t)ide analogs including virologic response (VR), biochemical response (BR), complete response (CR), and hepatocellular carcinoma (HCC) incidence among hepatitis B patients. We compared nucleos(t)ide analog treatment outcomes by sex. Methods: We performed a retrospective cohort study of 3388 treatment-naïve adult hepatitis B patients (1250 female, 2138 male) from the Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus consortium who initiated therapy with either entecavir or tenofovir from 22 sites (Argentina, Korea, Japan, Taiwan, and the United States). We used propensity-score matching to balance background characteristics of the male and female groups and competing-risks analysis to estimate the incidence and subdistribution hazard ratios (SHRs) of VR, BR, CR, and HCC. Results: Females (vs males) were older (52.0 vs 48.6 y); less likely to be overweight/obese (49.3% vs 65.7%), diabetic (9.9% vs 13.1%), or cirrhotic (27.9% vs 33.0%); and had a lower HBV DNA level (5.9 vs 6.0 log10 IU/mL) and alanine aminotransferase level (91 vs 102 IU/L) (all P <.01). However, after propensity-score matching, relevant background characteristics were balanced between the 2 groups. Females (vs males) had similar 5-year cumulative VR (91.3% vs 90.3%; P =.40) and HCC incidence rates (5.1% vs 4.4%; P =.64), but lower BR (84.0% vs 90.9%; P <.001) and CR (78.8% vs 83.4%; P =.016). Males were more likely to achieve BR (SHR, 1.31; 95% CI, 1.17–1.46; P <.001) and CR (SHR, 1.16; 95% CI, 1.03–1.31; P =.016), but VR and HCC risks were similar. Conclusions: Sex differences exist for treatment outcomes among hepatitis B patients. Male sex was associated with a 16% higher likelihood of clinical remission and a 31% higher likelihood of biochemical response than females, while virologic response and HCC incidence were similar between the 2 groups.

키워드

Antiviral TherapyBiochemical ResponseComplete ResponseVirologic ResponseRISKAGE
제목
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study
저자
Chau, AngelaYeh, Ming-LunTsai, Pei-ChienHuang, Daniel Q.Kim, Sung EunTrinh, HuyYoon, Eileen L.Oh, HyunwooJeong, Jae YoonAhn, Sang BongAn, JihyunTseng, Cheng-HaoHsu, Yao-ChunJeong, Soung WonCho, Yong KyunShim, Jae-JunKim, Hyoung SuIto, TakanoriMarciano, SebastiánKawashima, KeigoSuzuki, TakanoriWatanabe, TsunamasaNozaki, AkitoIshikawa, ToruInoue, KaoriEguchi, YuichiroUojima, HarukiAbe, HiroshiTakahashi, HirokazuChuma, MakotoIshigami, MasatoshiHoang, Joseph K.Maeda, MayumiHuang, Chung-FengGadano, AdrianDai, Chia-YenHuang, Jee-FuTanaka, YasuhitoChuang, Wan-LongLim, Seng GeeCheung, RamseyYu, Ming-LungJun, Dae-WonNguyen, Mindie H.
DOI
10.1016/j.cgh.2023.09.002
발행일
2024-03
유형
Article
저널명
Clinical Gastroenterology and Hepatology
22
3
페이지
572 ~ 580